Nassiri Nariman, Nouri-Mahdavi Kouros, Coleman Anne L
Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
Saudi J Ophthalmol. 2011 Oct;25(4):317-27. doi: 10.1016/j.sjopt.2011.07.002. Epub 2011 Jul 30.
Pediatric glaucoma is potentially a blinding disease. Although goniotomy and trabeculotomy are associated with good early success rates, eventually 20% of these procedures fail and many children will require additional surgery to control the IOP in the long-term. In this review, we reported that adequate IOP control can be achieved with the placement of Ahmed glaucoma valve and can last 5 or more years. However, most patients will need one or more glaucoma medications at some point after surgery. In addition, the implants may be associated with pupillary irregularities, lenticular opacification as well as tube-related complications, particularly in the first year of life, as the globe is enlarging with age.
小儿青光眼有可能致盲。尽管前房角切开术和小梁切开术早期成功率较高,但最终这些手术中有20%会失败,许多儿童长期需要额外手术来控制眼压。在本综述中,我们报告了通过植入艾哈迈德青光眼引流阀可实现充分的眼压控制,且这种控制可持续5年或更长时间。然而,大多数患者术后在某个阶段需要一种或多种青光眼药物。此外,植入物可能会导致瞳孔不规则、晶状体混浊以及与引流管相关的并发症,尤其是在生命的第一年,因为眼球会随着年龄增长而增大。